SC
MJN

Salzman & Co’s Mead Johnson Nutrition Company MJN Stock Holding History

Salzman & Co’s Portfolio MJN Stock Details MJN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-107,714
Closed -$8M – 8
2013
Q3 		$8M Buy
+107,714
New +$8.08M 7.16% 6

Other funds holding MJN

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Salzman & Co's MJN Position: Q4 2013 in Review

Salzman & Co sold out of Mead Johnson Nutrition Company (MJN) in Q4 2013, closing a stake of 107,714 shares — an estimated $8M sold.

Salzman & Co first reported a position in MJN in Q3 2013 and held it in 1 quarter. The position peaked at $8M in Q3 2013. 483 funds tracked by Wall St. Rank hold MJN as of Q4 2013.

  • Salzman & Co reported no remaining Mead Johnson Nutrition Company position as of Q4 2013 after selling out during the quarter.
  • Salzman & Co sold 107,714 Mead Johnson Nutrition Company shares in Q4 2013, an estimated $8M.
  • Salzman & Co first reported a position in Mead Johnson Nutrition Company in Q3 2013 and held it in 1 quarter.
  • Salzman & Co's Mead Johnson Nutrition Company position peaked at $8M in Q3 2013.
  • 483 funds tracked by Wall St. Rank held Mead Johnson Nutrition Company as of Q4 2013.

Based on Salzman & Co's 13F filing for Q4 2013, filed 14 Feb 2014.